IN2013MU03427A - - Google Patents

Info

Publication number
IN2013MU03427A
IN2013MU03427A IN3427MU2013A IN2013MU03427A IN 2013MU03427 A IN2013MU03427 A IN 2013MU03427A IN 3427MU2013 A IN3427MU2013 A IN 3427MU2013A IN 2013MU03427 A IN2013MU03427 A IN 2013MU03427A
Authority
IN
India
Prior art keywords
fingolimod
salts
relates
dosage forms
oral dosage
Prior art date
Application number
Other languages
English (en)
Inventor
Girish Kumar Jain
Venkataramana Naidu
Saurabh Gupta
Prafulla Joshi
Anubhav Nagal
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN3427MU2013 priority Critical patent/IN2013MU03427A/en
Publication of IN2013MU03427A publication Critical patent/IN2013MU03427A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3427MU2013 2013-10-30 2013-10-30 IN2013MU03427A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3427MU2013 IN2013MU03427A (es) 2013-10-30 2013-10-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3427MU2013 IN2013MU03427A (es) 2013-10-30 2013-10-30

Publications (1)

Publication Number Publication Date
IN2013MU03427A true IN2013MU03427A (es) 2015-07-31

Family

ID=54397482

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3427MU2013 IN2013MU03427A (es) 2013-10-30 2013-10-30

Country Status (1)

Country Link
IN (1) IN2013MU03427A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018178744A1 (en) * 2017-03-29 2018-10-04 Deva Holding Anonim Sirketi Stable formulations of fingolimod

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018178744A1 (en) * 2017-03-29 2018-10-04 Deva Holding Anonim Sirketi Stable formulations of fingolimod

Similar Documents

Publication Publication Date Title
PH12017500281A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
MX2021015234A (es) Composiciones y metodos que comprenden bupropion o compuestos relacionados y dextrometorfano.
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
PH12016501122A1 (en) Delayed release compositions of linaclotide
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
EA201791110A1 (ru) Сублингвальное введение рилузола
MX2016004741A (es) Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico.
UA117032C2 (uk) Селективний інгібітор фосфатидилінозитол-3-кінази-гамма
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
PH12014502065A1 (en) Vesicular formulations
NZ707636A (en) Ingenol-derived compounds that can be used for treating cancer
MX359887B (es) Composicion masticable para administracion oral y proceso para preparar la misma.
IN2013MU01111A (es)
MX366309B (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
GR1008228B (el) Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου
IN2013MU03428A (es)
IN2013MU03427A (es)
PH12015502703A1 (en) Pharmaceutical compositions
IN2013CH04314A (es)
MX2017013103A (es) Metodos para el tratamiento de trastornos cardiovasculares.
TW201613600A (en) Piperazinyl derivative reduces HFD-induced accumulation of fat in the liver, therapeutically
MX2016002139A (es) Composicion farmaceutica y uso del (2-cianoetil)fosfonato de dietilo.
MX2016003763A (es) Terapia de combinacion con laquinimod para tratamiento de esclerosis multiple.